Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123990144 | 12399014 | 4 | F | 20120208 | 20160818 | 20160524 | 20160825 | EXP | US-ASTRAZENECA-2016SE53288 | ASTRAZENECA | 21385.00 | DY | F | Y | 53.90000 | KG | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123990144 | 12399014 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | U | 20541 | TABLET | |||||||||
| 123990144 | 12399014 | 2 | SS | FASLODEX | FULVESTRANT | 1 | Intramuscular | U | 0 | INJECTION | |||||||||
| 123990144 | 12399014 | 3 | SS | TAMOXIFEN | TAMOXIFEN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 123990144 | 12399014 | 4 | SS | TAXOL | PACLITAXEL | 1 | Intravenous (not otherwise specified) | Y | U | 0 | |||||||||
| 123990144 | 12399014 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 4 CYCLES, NEOAD- | U | U | 0 | INJECTION | |||||||
| 123990144 | 12399014 | 6 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | 4 CYCLES, NEOAD | U | U | 0 | ||||||||
| 123990144 | 12399014 | 7 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | U | 0 | 125 | MG | CAPSULE | QD | ||||||
| 123990144 | 12399014 | 8 | C | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | 0 | ||||||||||||
| 123990144 | 12399014 | 9 | C | XELODA | CAPECITABINE | 1 | 0 | ||||||||||||
| 123990144 | 12399014 | 10 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 123990144 | 12399014 | 11 | C | EXEMESTANE. | EXEMESTANE | 1 | 0 | ||||||||||||
| 123990144 | 12399014 | 12 | C | CALCIUM 600 + D3 | 2 | 0 | |||||||||||||
| 123990144 | 12399014 | 13 | C | MULTIVITAMIN | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123990144 | 12399014 | 4 | Breast cancer female |
| 123990144 | 12399014 | 5 | Breast cancer metastatic |
| 123990144 | 12399014 | 6 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123990144 | 12399014 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123990144 | 12399014 | Anal incontinence | |
| 123990144 | 12399014 | Breast cancer recurrent | |
| 123990144 | 12399014 | Diarrhoea | |
| 123990144 | 12399014 | Disease progression | |
| 123990144 | 12399014 | Fatigue | |
| 123990144 | 12399014 | Hypoaesthesia oral | |
| 123990144 | 12399014 | Neuropathy peripheral | |
| 123990144 | 12399014 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123990144 | 12399014 | 1 | 20140520 | 0 | ||
| 123990144 | 12399014 | 3 | 20131210 | 20140520 | 0 | |
| 123990144 | 12399014 | 4 | 20120208 | 0 | ||
| 123990144 | 12399014 | 5 | 20111108 | 0 | ||
| 123990144 | 12399014 | 6 | 20111108 | 0 | ||
| 123990144 | 12399014 | 9 | 201602 | 0 |